STOCK TITAN

Stephen Sabba (NASDAQ: LGND) sells 2,034 shares for $409,851

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LGND reported an insider sale. Stephen L. Sabba reported the sale of 2,034 common shares on 03/03/2026 with an aggregate figure shown as $409,851.00 in the filing. The notice also records an earlier exercised block of 1,000 shares on 03/05/2024 noted as "Exercised Shares" for cash.

Positive

  • None.

Negative

  • None.

Insights

Routine disclosure of an insider sale with clear size and dates.

The filing lists a reported sale of 2,034 common shares on 03/03/2026 and shows $409,851.00 alongside that row; the excerpt treats these as the selling-row values. The filing also records an earlier exercise of 1,000 shares on 03/05/2024 paid in cash.

These items are administrative disclosures under Rule 144. The cash‑flow treatment and whether proceeds went to the reporting person or an associated entity are not detailed in the excerpt; subsequent filings or broker confirmations would provide further context.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did LGND insider Stephen L. Sabba report on 03/03/2026?

He reported a sale of 2,034 common shares on 03/03/2026, with an associated aggregate figure listed as $409,851.00. The filing presents these numbers in the "Securities Sold During The Past 3 Months" row.

Does the filing show any exercised securities for LGND?

Yes. The excerpt records an "Exercised Shares" row showing 1,000 common shares exercised on 03/05/2024 and paid in cash. That line is labeled "Issuer" and indicates exercise activity.

Is the cash‑flow destination of the sale proceeds specified for LGND?

No. The provided excerpt lists $409,851.00 with the sale row but does not state who received the proceeds or how they were used. The filing text in the excerpt lacks a cash‑flow beneficiary statement.

What form type is this LGND filing and what does it mean?

This is a Form 144 disclosure for proposed or recent resale under Rule 144. It notifies the market of an insider sale of restricted or control securities, as shown by the reported sale and exercise rows.

Are there other transaction dates shown in the excerpt for LGND?

Yes. Aside from 03/03/2026, the excerpt shows an exercise date of 03/05/2024 for 1,000 shares and an entry dated 03/05/2024 labeled "Exercised Shares" with cash consideration.
Ligand Pharma

NASDAQ:LGND

View LGND Stock Overview

LGND Rankings

LGND Latest News

LGND Latest SEC Filings

LGND Stock Data

4.06B
19.47M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO